Sitewide Sale! 15% OFF Use Code EPX15 *
Senvelgo Oral Solution for Cats - 15 mg/mL (12 mL) - [Feline Comprehensive Support]
- Description
- Ingredients
- Directions
- Reviews
Description
📄 View the official Senvelgo Oral Solution Product Insert (PDF)
Senvelgo Oral Solution is the first and only FDA-approved SGLT2 (sodium-glucose co-transporter 2) inhibitor developed specifically for cats. This innovative treatment is designed to manage chronic kidney disease (CKD)—a progressive and common condition in aging felines that leads to increased thirst, excessive urination, weight loss, decreased appetite, and overall decline in health.
Senvelgo contains the active ingredient velagliflozin, which inhibits the SGLT2 protein in the kidneys. By reducing the reabsorption of glucose and sodium, it lowers urinary protein levels (proteinuria)—a key factor in kidney damage. This targeted mechanism helps preserve kidney function and enhances the quality of life in cats with CKD.
Veterinary supervision is recommended throughout treatment to monitor response and ensure proper dosing. Routine evaluations may include blood tests, urinalysis, and assessments of hydration, glucose, and kidney function.
With its palatable, once-daily oral formulation, Senvelgo offers a stress-free option for cat owners and a significant breakthrough in feline nephrology. It supports slowing CKD progression while promoting comfort and well-being in affected cats.
Indications:
Senvelgo Oral Solution is indicated to reduce the risk of kidney function decline in cats diagnosed with chronic kidney disease (CKD), particularly in cases where proteinuria (excess urinary protein) is present. It may be used as part of a comprehensive management plan for cats with IRIS stages 1–3 CKD.
Key Benefits:
- Easy Daily Dosing: Simple once-daily oral administration with low risk of hypoglycemia.
- Fast Stabilization: Helps control glycemic levels in most cats within 7 days, typically without dose adjustments.
- Streamlined Monitoring: Stabilized cats generally require less frequent diagnostics and monitoring.
Ingredients
| Type | Ingredient | Description / Function |
|---|---|---|
| Active Ingredient | Velagliflozin | SGLT2 inhibitor used to manage chronic kidney disease (CKD) in cats by reducing proteinuria |
| Inactive Ingredients | Not specified | May include purified water, stabilizers, and flavoring agents – consult product label or manufacturer for full list |
Directions
- Consult Your Veterinarian: Before starting Senvelgo Oral Solution, consult a veterinarian experienced in feline care. They will determine the correct dosage based on your cat’s weight, age, and chronic kidney disease (CKD) progression.
- Dosage Instructions: Administer once daily, exactly as prescribed. Never adjust the dose or frequency without veterinary approval.
- How to Administer: Shake the bottle well before each use. Use the included oral dosing syringe for accurate measurement. The solution may be dispensed directly into your cat’s mouth or mixed with a small amount of food for easier administration.
- Monitoring Guidelines: Schedule regular veterinary checkups to monitor kidney function, hydration levels, and glucose levels. Routine bloodwork and urinalysis are often recommended to track response to treatment.
- Hydration: Ensure your cat has access to clean, fresh water at all times to support kidney health and prevent dehydration.
- Precautions: Do not use Senvelgo in cats with diabetes mellitus, dehydration, or low blood pressure unless directed by your veterinarian.
- Missed Dose: If a dose is missed, skip it and resume the regular schedule. Do not double the dose to compensate for a missed one.
- Storage Instructions: Store at controlled room temperature. Keep away from direct sunlight. Always keep out of reach of children and pets.
